BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36150819)

  • 1. Analytical Principles of Cancer Next Generation Sequencing.
    Gindin T; Hsiao SJ
    Clin Lab Med; 2022 Sep; 42(3):395-408. PubMed ID: 36150819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles and Validation of Bioinformatics Pipeline for Cancer Next-Generation Sequencing.
    Roy S
    Clin Lab Med; 2022 Sep; 42(3):409-421. PubMed ID: 36150820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis.
    Ascierto PA; Bifulco C; Palmieri G; Peters S; Sidiropoulos N
    J Mol Diagn; 2019 Sep; 21(5):756-767. PubMed ID: 31251989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics.
    Sonmezler O; Boga I; Bisgin A
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
    Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.
    Goswami RS; Luthra R; Singh RR; Patel KP; Routbort MJ; Aldape KD; Yao H; Dang HD; Barkoh BA; Manekia J; Medeiros LJ; Roy-Chowdhuri S; Stewart J; Broaddus RR; Chen H
    Am J Clin Pathol; 2016 Feb; 145(2):222-37. PubMed ID: 27124905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinician's Guide to Bioinformatics for Next-Generation Sequencing.
    Larson NB; Oberg AL; Adjei AA; Wang L
    J Thorac Oncol; 2023 Feb; 18(2):143-157. PubMed ID: 36379355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Canadian guideline on the use of next-generation sequencing in oncology.
    Yip S; Christofides A; Banerji S; Downes MR; Izevbaye I; Lo B; MacMillan A; McCuaig J; Stockley T; Yousef GM; Spatz A
    Curr Oncol; 2019 Apr; 26(2):e241-e254. PubMed ID: 31043833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
    Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
    J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Architecture of a Precision Oncology Platform.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning random forest for predicting oncosomatic variant NGS analysis.
    Pellegrino E; Jacques C; Beaufils N; Nanni I; Carlioz A; Metellus P; Ouafik L
    Sci Rep; 2021 Nov; 11(1):21820. PubMed ID: 34750410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics elio Tissue Complete Kitted Solution.
    Deak KL; Jackson JB; Valkenburg KC; Keefer LA; Robinson Gerding KM; Angiuoli SV; Datto MB; McCall SJ
    J Mol Diagn; 2021 Oct; 23(10):1324-1333. PubMed ID: 34314880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
    Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
    Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Methods: Clinical Utilization and Designing a Test Menu.
    Ewalt MD; Hsiao SJ
    Clin Lab Med; 2024 Jun; 44(2):123-135. PubMed ID: 38821636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-Year Laboratory Performance of the First College of American Pathologists In Silico Next-Generation Sequencing Bioinformatics Proficiency Testing Surveys.
    Furtado LV; Souers RJ; Vasalos P; Halley JG; Aisner DL; Nagarajan R; Voelkerding KV; Merker JD; Konnick EQ
    Arch Pathol Lab Med; 2023 Feb; 147(2):137-142. PubMed ID: 35671151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the success of next-generation sequencing in cytology specimens.
    Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
    Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection.
    Schlaberg R; Chiu CY; Miller S; Procop GW; Weinstock G; ;
    Arch Pathol Lab Med; 2017 Jun; 141(6):776-786. PubMed ID: 28169558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.